Literature DB >> 27487478

Assessing patient outcomes and cost-effectiveness of nurse-led follow-up for women with breast cancer - have relevant and sensitive evaluation measures been used?

Maria Browall1,2, Christina Forsberg2, Yvonne Wengström2,3.   

Abstract

AIMS AND
OBJECTIVES: To explore how interventions using nurse-led follow-up in breast cancer care have been evaluated with a focus on patient outcomes and cost-effectiveness.
BACKGROUND: As part of the advancement of breast care, nurse-led follow-up is increasingly used as an alternative to routine hospital follow-up in outpatient clinics. There is evidence suggesting that patients appear to be satisfied with the nurse-led follow-up, but there is a lack of evidence of whether this perception equates to patients' satisfaction with the model of physician-led follow-up.
DESIGN: Systematic review.
METHOD: Three databases were searched, and 29 RCT were initially screened. Finally, 13 articles were critically appraised. Searches included articles between 2005-2013. The quality of appraisal assessment was inspired by the GRADE system.
RESULTS: The results show that there are many different instruments used when evaluating nurse-led follow-up, which makes it difficult to compare the studies. Several of the studies used QoL as an outcome measure; this is a broad concept that includes several aspects ranging from social role and psychosocial issues to symptoms and therefore difficult to use as an outcome measure. Only two of the studies made any cost-effective analyses, and the results are hard to interpret.
CONCLUSIONS: Nurse-led follow-up can potentially result in better continuity of care and the availability of more time to provide psychosocial support and address patients' information needs. However, more well-conducted research is needed before equivalence to physician-led follow-up can be assessed in terms of survival, recurrence, patient well-being and cost-effectiveness. RELEVANCE TO CLINICAL PRACTICE: Results from well-conducted evaluation studies of nurse-led services based on theory are needed so that relevant interventions can be implemented in clinical practice. There is a need to in future studies include cost-effectiveness analyses to compare nurse-led services with other types of follow-up.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Quality of Life; breast cancer; cost-effectiveness; nurse-led follow-up; psychosocial support; symptoms

Mesh:

Year:  2017        PMID: 27487478     DOI: 10.1111/jocn.13496

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  6 in total

Review 1.  Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature.

Authors:  Amy J Davidoff; Kaitlin Akif; Michael T Halpern
Journal:  J Natl Cancer Inst Monogr       Date:  2022-07-05

2.  Systematic reviews as a "lens of evidence": Determinants of cost-effectiveness of breast cancer screening.

Authors:  Olena Mandrik; Obinna Ikechukwu Ekwunife; Filip Meheus; Johan L Hans Severens; Stefan Lhachimi; Carin A Uyl-de Groot; Raul Murillo
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

Review 3.  Mobile health applications for the care of patients with breast cancer: A scoping review.

Authors:  Tingting Cai; Yueshi Huang; Yuxia Zhang; Zhenqi Lu; Qingmei Huang; Changrong Yuan
Journal:  Int J Nurs Sci       Date:  2021-08-25

Review 4.  Improved models of care for cancer survivors.

Authors:  Michael Jefford; Doris Howell; Qiuping Li; Karolina Lisy; Jane Maher; Catherine M Alfano; Meg Rynderman; Jon Emery
Journal:  Lancet       Date:  2022-04-16       Impact factor: 202.731

5.  Satisfaction with Nurse-led Follow-up in Prostate Cancer Patients-A Nationwide Population-based Study.

Authors:  Oskar Bergengren; Helena Kaihola; Ann-Charlotte Borgefeldt; Eva Johansson; Hans Garmo; Anna Bill-Axelson
Journal:  Eur Urol Open Sci       Date:  2022-02-12

6.  Analyzing economic feasibility for investing in nursing care: Evidence from panel data analysis in 35 OECD countries.

Authors:  Arshia Amiri; Tytti Solankallio-Vahteri
Journal:  Int J Nurs Sci       Date:  2019-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.